The importance of understanding the infectious microenvironment

Leclercq, 2013, EUCAST expert rules in antimicrobial susceptibility testing, Clin Microbiol Infect, 19, 141, 10.1111/j.1469-0691.2011.03703.x Parker, 2018, Reproducibility of antimicrobial test methods, Sci Rep, 8, 10.1038/s41598-018-30282-3 Høiby, 2015, ESCMID guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 Kragh, 2014, Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients, Infect Immun, 82, 4477, 10.1128/IAI.01969-14 Crabbe, 2019, Antimicrobial tolerance and metabolic adaptations in microbial biofilms, Trends Microbiol, 27, 850, 10.1016/j.tim.2019.05.003 Cornforth, 2018, Pseudomonas aeruginosa transcriptome during human infection, Proc Natl Acad Sci USA, 115, E5125, 10.1073/pnas.1717525115 Stacy, 2014, Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection, Proc Natl Acad Sci USA, 111, 7819, 10.1073/pnas.1400586111 Blevins, 2010, Robert Koch and the ‘golden age’ of bacteriology, Int J Infect Dis, 14, e744, 10.1016/j.ijid.2009.12.003 Worlitzsch, 2002, Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients, J Clin Invest, 109, 317, 10.1172/JCI0213870 Xu, 2016, In vivo gene expression in a Staphylococcus aureus prosthetic joint infection characterized by RNA sequencing and metabolomics: a pilot study, BMC Microbiol, 16, 80, 10.1186/s12866-016-0695-6 Rossi, 2018, High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs, Nat Commun, 9, 10.1038/s41467-018-05944-5 Kolpen, 2015, Denitrification by cystic fibrosis pathogens—Stenotrophomonas maltophilia is dormant in sputum, Int J Med Microbiol, 305, 1, 10.1016/j.ijmm.2014.07.002 DePas, 2016, Exposing the three-dimensional biogeography and metabolic states of pathogens in cystic fibrosis sputum via hydrogel embedding, clearing, and rRNA labeling, mBio, 7, e00796, 10.1128/mBio.00796-16 Brown, 2008, Revisiting the host as a growth medium, Nat Rev Microbiol, 6, 657, 10.1038/nrmicro1955 Smith, 1998, What happens to bacterial pathogens in vivo?, Trends Microbiol, 6, 239, 10.1016/S0966-842X(98)01250-5 Stewart, 2014, Biophysics of biofilm infection, Pathog Dis, 70, 212, 10.1111/2049-632X.12118 Stewart, 2015, Antimicrobial tolerance in biofilms, Microbiol Spectr, 3, 10.1128/microbiolspec.MB-0010-2014 Fisher, 2017, Persistent bacterial infections and persister cells, Nat Rev Microbiol, 15, 453, 10.1038/nrmicro.2017.42 Nguyen, 2011, Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria, Science, 334, 982, 10.1126/science.1211037 Bernier, 2013, Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin, PLoS Genet, 9, 10.1371/journal.pgen.1003144 Zuroff, 2010, Robustness analysis of culturing perturbations on Escherichia coli colony biofilm beta-lactam and aminoglycoside antibiotic tolerance, BMC Microbiol, 10, 185, 10.1186/1471-2180-10-185 Burmolle, 2014, Interactions in multispecies biofilms: do they actually matter?, Trends Microbiol, 22, 84, 10.1016/j.tim.2013.12.004 Stewart, 2019, Conceptual model of biofilm antibiotic tolerance that integrates phenomena of diffusion, metabolism, gene expression, and physiology, J Bacteriol, 201, e00307, 10.1128/JB.00307-19 Heim, 2020, Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection, Nat Microbiol, 5, 1271, 10.1038/s41564-020-0756-3 Hajdamowicz, 2019, The impact of hypoxia on the host-pathogen interaction between neutrophils and Staphylococcus aureus, Int J Mol Sci, 20, 10.3390/ijms20225561 Traven, 2019, Central metabolic interactions of immune cells and microbes: prospects for defeating infections, EMBO Rep, 20, 10.15252/embr.201947995 Røder, 2020, Unravelling interspecies interactions across heterogeneities in complex biofilm communities, Environ Microbiol, 22, 5, 10.1111/1462-2920.14834 Rossi, 2021, Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis, Nat Rev Microbiol, 19, 331, 10.1038/s41579-020-00477-5 Yang, 2017, Antibiotic-induced changes to the host metabolic environment inhibit drug efficacy and alter immune function, Cell Host Microbe, 22, 757, 10.1016/j.chom.2017.10.020 Jensen, 2019, In vivo gentamicin susceptibility test for prevention of bacterial biofilms in bone tissue and on implants, Antimicrob Agents Chemother, 63, e01889, 10.1128/AAC.01889-18 Bue, 2018, Single-dose bone pharmacokinetics of vancomycin in a porcine implant-associated osteomyelitis model, J Orthop Res, 36, 1093, 10.1002/jor.23776 Jensen, 2017, Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response, APMIS, 125, 276, 10.1111/apm.12668 Lewis, 2014, Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns, Front Cell Infect Microbiol, 4, 71, 10.3389/fcimb.2014.00071 Lobritz, 2015, Antibiotic efficacy is linked to bacterial cellular respiration, Proc Natl Acad Sci USA, 112, 8173, 10.1073/pnas.1509743112 Sønderholm, 2017, Pseudomonas aeruginosa aggregate formation in an alginate bead model system exhibits in vivo-like characteristics, Appl Environ Microbiol, 83, e00113, 10.1128/AEM.00113-17 Edmondson, 2014, Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors, Assay Drug Dev Technol, 12, 207, 10.1089/adt.2014.573 Rohwer, 2011, Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways, Drug Resist Updat, 14, 191, 10.1016/j.drup.2011.03.001 Xu, 2021, Microglia in neurodegenerative diseases, Neural Regen Res, 16, 270, 10.4103/1673-5374.290881 DeBerardinis, 2008, Is cancer a disease of abnormal cellular metabolism? New angles on an old idea, Genet Med, 10, 767, 10.1097/GIM.0b013e31818b0d9b Roizin-Towle, 1978, Studies with bleomycin and misonidazole on aerated and hypoxic cells, Br J Cancer, 37, 254, 10.1038/bjc.1978.34 Harris, 2002, Hypoxia—a key regulatory factor in tumour growth, Nat Rev Cancer, 2, 38, 10.1038/nrc704 Tredan, 2007, Drug resistance and the solid tumor microenvironment, J Natl Cancer Inst, 99, 1441, 10.1093/jnci/djm135 Steele, 2019, An organoid-based preclinical model of human gastric cancer, Cell Mol Gastroenterol Hepatol, 7, 161, 10.1016/j.jcmgh.2018.09.008 Vlachogiannis, 2018, Patient-derived organoids model treatment response of metastatic gastrointestinal cancers, Science, 359, 920, 10.1126/science.aao2774 Gambardella, 2020, Personalized medicine: recent progress in cancer therapy, Cancers (Basel), 12, 10.3390/cancers12041009 Jensen, 2019, Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: not just hot air, Biofilm, 1, 10.1016/j.bioflm.2019.100008 Coenye, 2018, Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?, Clin Microbiol Infect, 24, 570, 10.1016/j.cmi.2018.01.003 Cornforth, 2020, Quantitative framework for model evaluation in microbiology research using Pseudomonas aeruginosa and cystic fibrosis infection as a test case, mBio, 11, e03042, 10.1128/mBio.03042-19